Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.050
+0.060 (3.02%)
At close: May 16, 2025, 4:00 PM
2.040
-0.010 (-0.49%)
After-hours: May 16, 2025, 4:05 PM EDT
Celularity Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Celularity.
Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Celularity.
Recommendation Trends
Rating | Aug '22 | Sep '22 | Oct '22 | Nov '22 | Dec '22 | Jan '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 1 | 1 | 1 | 1 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 3 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $50 → $10 | Hold → Sell | Downgrades | $50 → $10 | +387.80% | Jan 30, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $25 | Strong Buy | Maintains | $150 → $25 | +1,119.51% | Jan 30, 2023 |
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 22, 2022 |
Morgan Stanley | Morgan Stanley | Hold Maintains $80 → $50 | Hold | Maintains | $80 → $50 | +2,339.02% | Sep 12, 2022 |
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $150 | Strong Buy | Initiates | $150 | +7,217.07% | Aug 25, 2022 |
Financial Forecast
Revenue This Year
66.85M
from 54.22M
Increased by 23.29%
Revenue Next Year
n/a
from 66.85M
EPS This Year
-0.43
from -2.64
EPS Next Year
n/a
from -0.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 |
---|---|
High | 68.8M |
Avg | 66.8M |
Low | 64.2M |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | 26.9% |
Avg | 23.3% |
Low | 18.5% |
EPS Forecast
EPS | 2025 |
---|---|
High | -0.44 |
Avg | -0.43 |
Low | -0.41 |
EPS Growth
EPS Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.